Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKRP) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to 6.02%.

  • Bruker's EBITDA Margin fell 139000.0% to 6.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.83%, marking a year-over-year decrease of 69500.0%. This contributed to the annual value of 7.39% for FY2024, which is 73500.0% down from last year.
  • Latest data reveals that Bruker reported EBITDA Margin of 6.02% as of Q3 2025, which was down 139000.0% from 1.49% recorded in Q2 2025.
  • In the past 5 years, Bruker's EBITDA Margin registered a high of 18.49% during Q4 2022, and its lowest value of 6.02% during Q3 2025.
  • In the last 5 years, Bruker's EBITDA Margin had a median value of 7.88% in 2023 and averaged 8.01%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 67000bps in 2022, then crashed by -139000bps in 2025.
  • Quarter analysis of 5 years shows Bruker's EBITDA Margin stood at 11.79% in 2021, then skyrocketed by 57bps to 18.49% in 2022, then plummeted by -35bps to 12.11% in 2023, then plummeted by -43bps to 6.94% in 2024, then plummeted by -187bps to 6.02% in 2025.
  • Its EBITDA Margin stands at 6.02% for Q3 2025, versus 1.49% for Q2 2025 and 3.97% for Q1 2025.